Armistice Capital, LLC 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:49 pm Unchanged |
2024-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 5,096,251 11.430% |
0 (Unchanged) |
Filing |
| 2024-11-14 4:46 pm Purchase |
2024-09-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 5,096,251 10.820% |
470,061 (+10.16%) |
Filing |
| 2024-02-14 2:21 pm Purchase |
2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 4,626,190 9.990% |
1,629,079 (+54.35%) |
Filing |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing |
| 2023-02-14 11:59 am Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing |